Nemaura Medical Scales-Up Pilot Expansion Of proBEAT; 56 Corporations In The U.S. Signed Up For Pilots In June 2023
Portfolio Pulse from Happy Mohamed
Nemaura Medical announces the next commercialization stage of its proBEAT sensor and AI-based feedback platform, augmenting the BEAT diabetes program. 56 corporations in the U.S. have signed up for pilots in June 2023, which are intended as a precursor to revenue-generating contracts.
June 27, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Nemaura Medical's proBEAT sensor and AI-based feedback platform pilot expansion has 56 U.S. corporations signed up for June 2023, potentially leading to revenue-generating contracts.
The pilot expansion of Nemaura Medical's proBEAT sensor and AI-based feedback platform has attracted 56 U.S. corporations, which could lead to revenue-generating contracts in the future. This positive development is likely to have a short-term positive impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100